...
首页> 外文期刊>Internal medicine. >Sitosterolemia Exhibiting Severe Hypercholesterolemia with Tendon Xanthomas Due to Compound Heterozygous ABCG5 Gene Mutations Treated with Ezetimibe and Alirocumab
【24h】

Sitosterolemia Exhibiting Severe Hypercholesterolemia with Tendon Xanthomas Due to Compound Heterozygous ABCG5 Gene Mutations Treated with Ezetimibe and Alirocumab

机译:由于用ezetimibe和Alirocumab处理的化合物杂合子ABCG5基因突变,患有肌腱Xanthomas的阳腱瘤症。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

We herein report a rare case presenting with severe hypercholesterolemia, massive Achilles tendon xanthomas, and multi-vessel coronary artery disease. Initially, the patient was misdiagnosed with familial hypercholesterolemia. However, a genetic analysis using our custom sequencing panel covering genes associated with Mendelian lipid disorders revealed him to have a genetic basis of sitosterolemia with compound heterozygous mutations in the adenosine triphosphate binding cassette subfamily G5 ( ABCG5 ) gene. A comprehensive genetic analysis can be particularly useful for diagnosing cases with severe phenotypes, leading to appropriate and medical therapies. Our patient was refractory to statins, whereas ezetimibe and PCSK9 inhibitor with a low-plant-sterol diet successfully reduced his serum levels of low-density lipoprotein cholesterol.
机译:我们在此报告罕见患有严重的高胆固醇血症,大胆肌腱Xanthomas和多血管冠状动脉疾病的罕见情况。最初,患者被家族性高胆固醇血症误诊。然而,使用我们的定制测序面板覆盖与孟德尔脂质疾病相关的基因的遗传分析揭示了他在腺苷三磷酸三磷酸盐结合盒亚家族G5(ABCG5)基因中具有化合物杂合突变的遗传基础。综合遗传分析对于诊断患有严重表型的病例特别有用,导致适当和医疗疗法。我们的病人对他汀类药物难以忍受,而ezetimibe和PCSK9抑制剂,具有低植物甾醇饮食成功降低了他的血清水平的低密度脂蛋白胆固醇。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号